Ciplactin Syrup 200 ml

Babies: Use caution in children. Lactating mothers: Ciplactin syrup is contraindicated in lactating women. Pregnancy: Ciplactin syrup is considered safe to use during pregnancy. Animal studies have revealed that there are few or no adverse effects on the developing baby.
However, human studies are limited. Driving: Ciplactin syrup may cause dizziness, drowsiness, sedation, & hypotension and could affect the ability to drive. Alcohol: Avoid consumption of alcohol while taking ciplactin syrup as it may increase the risk of dizziness and drowsiness. Liver: Ciplactin syrup should be used in caution with patients suffering from liver disease. You may require a dose adjustment and regular monitoring of liver function.
Seek doctor advice before using this medication. Kidney: Ciplactin syrup should be used in caution with patients suffering from kidney disease.
You may require a dose adjustment and regular monitoring of kidney function. Seek doctor advice before using this medication.
.

Drowsiness Headache Fatigue Nervousness Dizziness Increased appetite Nausea Diarrhoea Abdominal pain Arthralgia Pharyngitis.

Ciplactin syrup is an antihistamine. It works by inhibiting the production of a natural substance (histamine) by your body during an allergic reaction.
This medication also inhibits the activity of another natural substance in your body (serotonin). .

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Avoid consuming alcohol as it may increase the risk of drowsiness and dizziness. • Do not drive and handle heavy machinery that requires your alertness and mental focus. • Do not stop the medication suddenly without informing your doctor..

Contraindicated • Ciplactin + Brofaromine: Concurrent use may lead to prolonged and intensified anticholinergic effects • Ciplactin + Clorgyline: Concurrent use may lead to prolonged and intensified anticholinergic effects • Ciplactin + Furazolidone: Concurrent use may lead to prolonged and intensified anticholinergic effects • Ciplactin + Iproniazid: Concurrent use may lead to prolonged and intensified anticholinergic effects • Ciplactin + Isocarboxazid: Concurrent use may lead to prolonged and intensified anticholinergic effects • Ciplactin + Lazabemide: Concurrent use may lead to prolonged and intensified anticholinergic effects Serious • Ciplactin + Amifampiridine: Concurrent use may lead to increased risk of seizures • Ciplactin + Buprroprion: Concurrent use may lead to increased risk of seizures • Ciplactin + Clozapine: Concurrent use may lead to increased risk of anticholinergic toxicity and gastrointestinal reactions • Ciplactin + Donepezil: Concurrent use may lead to reduced seizure threshold • Ciplactin + Glocagon: Concurrent use may lead to increased risk of gastrointestinal side effects Monitor closely • Ciplactin + Amantadine: Concurrent use may lead to potentiation of anticholinergic effects • Ciplactin + Fluoxetine: Concurrent use may lead to decreased fluoxetine efficacy • Ciplactin + Paroxetine: Concurrent use may lead to decreased paroxetine efficacy • Ciplactin + Protirelin: Concurrent use may lead to decreased thyroid-stimulating hormone response.